Schedule-dependent therapeutic gain from the combination of fractionated irradiation plus c-DDP and 5-FU or plus c-DDP and cyclophosphamide in mouse model systems-Reference-Cited by-同舟云学术

Schedule-dependent therapeutic gain from the combination of fractionated irradiation plus c-DDP and 5-FU or plus c-DDP and cyclophosphamide in mouse model systems

Published:1991-02 Issue:2 Volume:20 Page:227-232
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Kallman Robert F,Rapacchietta Diane,Zaghloul Mohamed S

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference18 articles.

1. Therapeutic enhancement in mice by clinically relevant dose and fractionation schedules of cis-diamminedichloroplatinum(II) and irradiation;Bartelink;Radiother. Oncol.,1986

2. The influence of time sequence of cisplatin administration and continuous low dose rate irradiation (CLDRI) on their combined effects on a murine squamous cell carcinoma;Fu;Int. J. Radiat. Oncol. Biol. Phys.,1985

3. Modification of the effects of continuous low dose rate irradiation by concurrent chemotherapy infusion;Fu;Int. J. Radiat. Oncol. Biol. Phys.,1984

4. Scheduledependent therapeutic gain from the combination of fractionated irradiation and cis-Diamminedichloroplatinum(II) in C3HKm mouse model systems;Kanazawa;Cancer Res.,1988

5. The effect of treatment in fractionated schedules with the combination of X-irradiation and six cytotoxic drugs on the RIF-1 tumor and normal mouse skin;Lelieveld;Int. J. Radiat. Oncol. Biol. Phys.,1985

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Timing of chemotherapy and radiation delivery for patients receiving chemoradiation for head and neck cancer: When does “concurrent” mean concurrent?;Oral Oncology;2023-10

2. Forphenicinol enhances the antitumor effects of cyclophosphamide in a model of squamous cell carcinoma;Cancer Chemotherapy and Pharmacology;2005-05-11

3. Postoperative adjuvant concurrent chemoradiotherapy improves survival rates for high-risk, early stage cervical cancer patients;Gynecologic Oncology;2005-02

4. The role of chemotherapy in locally advanced, metastatic and recurrent cervical cancer;Critical Reviews in Oncology/Hematology;2004-10

5. Chemoradiation: A new approach for the treatment of cervical cancer;International Journal of Gynecological Cancer;2003-09